Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akash Pawar
Observed name:
A. Pawar
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
Observed institutions:
Twitter (United States),
Gujarat Cancer & Research Institute,
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
ORCID:
0000-0003-0797-8098
Observed ORCID:
0000-0003-0797-8098
OpenAlex ID:
A5089016306
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
2024
·
Jyoti Bajpai
, Venkatesh Kapu
, et al.
·
The Lancet Oncology
·
46
A narrative review of survival analysis in oncology using R
2022
·
Akash Pawar
, Oindrila R. Chowdhury
, et al.
·
Cancer Research Statistics and Treatment
·
40
Impact of the geriatric assessment on cancer-directed systemic therapy in older Indian persons with cancer: An observational study
2022
·
Vanita Noronha
, Abhijith Rao
, et al.
·
Cancer Research Statistics and Treatment
·
23
Identification of key gene signatures for the overall survival of ovarian cancer
2022
·
Akash Pawar
, Oindrila Roy Chowdhury
, et al.
·
Journal of Ovarian Research
·
13
PDF
Genomic Profiling of Driver Gene Alterations in Patients With Non–Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center Experience of More Than 1200 Patients
2025
·
Minit Shah
, Vanita Noronha
, et al.
·
Clinical Lung Cancer
·
10
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma
2024
·
Vanita Noronha
, Vijay Maruti Patil
, et al.
·
JNCI Journal of the National Cancer Institute
·
10
Comprehensive Genomic Profiling of Indian Patients With Lung Cancer
2025
·
Shivani Sharma
, Vanita Noronha
, et al.
·
JCO Global Oncology
·
7
PSMA-PET-Guided Intraprostatic Boost in Prostate SBRT (PROBE): A Phase 2 Trial
2025
·
Maneesh Singh
, Aparna Katdare
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
7
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial
2022
·
V. Noronha
, V. M. Patil
, et al.
·
Esophagus
·
7
Clinico-Radiological Outcomes in WNT-Subgroup Medulloblastoma
2024
·
Shakthivel Mani
, Abhishek Chatterjee
, et al.
·
Diagnostics
·
6
PDF
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization
2025
·
Anant Gokarn
, Laxma Reddy
, et al.
·
Cytotherapy
·
5
CA 19-9 Surveillance Detects Recurrences Early and Contributes to Improvement in Survival in Resected Ampullary Cancers
2024
·
Manish S. Bhandare
, Gurudutt P. Varty
, et al.
·
Annals of Surgery
·
5
SurvHiDim: High Dimensional Survival Data Analysis
2021
·
Atanu Bhattacharjee
, Akash Pawar
·
5
PDF
A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer
2025
·
Kumar Prabhash
, Vanita Noronha
, et al.
·
European Journal of Cancer
·
4
Prevalence of cognitive impairment in patients receiving 5-fluoro-uracil containing chemotherapy: A systematic review and meta-analysis
2024
·
Anita R D’souza
, Jyoti Chaudhari
, et al.
·
Cancer Research Statistics and Treatment
·
4
Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in India
2024
·
Vanita Noronha
, Laboni Sarkar
, et al.
·
ecancermedicalscience
·
4
PDF
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population
2025
·
Hasmukh Jain
, Thomas Eipe
, et al.
·
JCO Global Oncology
·
3
Ten‐year follow‐up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult patients with bone sarcomas from a large cohort in a low‐income and middle‐income country
2024
·
Jyoti Bajpai
, Laboni Sarkar
, et al.
·
Cancer
·
3
PDF
Prognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers
2024
·
Kaival Gundavda
, Amit Chopde
, et al.
·
Annals of Surgical Oncology
·
3
Treatment Response to Neoadjuvant Therapy in Squamous Esophageal Cancer—Correlation Between Metabolic Response and Histopathology
2024
·
Abdeali Saif Arif Kaderi
, Jiwnani Sabita
, et al.
·
Journal of Gastrointestinal Cancer
·
3
Interplay of Postpancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insight from a Comprehensive Cohort Study of 1,594 Patients and Development of Predictive Nomograms
2026
·
Manish S Bhandare
, Kunal Nandy
, et al.
·
Journal of the American College of Surgeons
·
2
Outcomes and recurrence patterns following resection of T1 ampullary carcinomas: single centre experience of 92 cases
2025
·
Gurudutt P. Varty
, Arindam Mondal
, et al.
·
HPB
·
2
Tumor burden score as a prognostic factor in patients with intermediate and locally advanced hepatocellular carcinoma undergoing liver resection: an attempt to extend resectability criteria
2024
·
Kunal Nandy
, Shraddha Patkar
, et al.
·
HPB
·
2
PDF
A prospective study to assess cervical scar satisfaction following conventional open thyroidectomy for thyroid cancer
2024
·
Shivakumar Thiagarajan
, Abhishek Menon
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
2
A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer.
2023
·
Vanita Noronha
, Supriya Goud
, et al.
·
Journal of Clinical Oncology
·
2
Show more works
View as search
Works count:
67
Citation count:
226
H-index:
7
I10-index:
6
Year
Topic
Type